Four phase III studies of bictegravir/emtricitabine/tenofovir alafenamide meet primary endpoints May 31, 2017
Preliminary results show nearly 100% immune response rates in clinical study of Pennvax-GP May 25, 2017
Quadruplex sgRNAs/saCas9 AAV gene therapy results in successful HIV-1 provirus excision in vivo May 16, 2017
RSS